The newly designed CLB-ZW800 conjugate provides a promising strategy for utilizing the various kinds of hydrophobic anticancer drugs for tumor-targeted drug delivery and imaging, as well as phototherapy, thereby acting as a multifunctional phototherapeutic agent. Here, CLYBL is linked to neoplasm.